The IL‐4, IL‐13 and TNF‐α levels were significantly reduced in the spleen and lymph nodes of AD mice after the celastrol or Mdivi‐1 treatment (Figure 7B,C). This evidence concerns the gene IL13 and Alzheimer disease.